信号时域积分性质的一个推广应用

对信号进行运算（卷积运算，傅氏变换，拉纸变换）时，应用时域积分性质，得出由函数导数的运算式求取原函数的相应运算结果的一般性计算公式，使时域积分性质的应用得到推广。     

胜科1井钻井事故的预防与处理

胜科1井设计井深7 000 m,完钻井深7 026 m。在该井钻井过程中,针对上部大尺寸钻头破岩效率低、大井眼井壁稳定性差、大段盐膏层、膏岩层的塑性蠕变和塑性流动造成井眼复杂、超深井高温高压给钻井液性能的控制和水泥浆调控等带来的一系列技术难题,制定了一整套预防井下事故和复杂情况的技术措施,从而确保了该井的钻探成功。该井在钻井过程发生了2次断钻具事故和1次卡钻事故,根据超深井的特点,采取了较为稳妥的处理措施,同时,有针对性地研制了高效铣环和PDC钻头专用打捞器,3次事故处理均获得了成功,共耗时38.5 d。详细介绍了该井所采取的预防和处理钻井事故的技术措施,可为其他超深井的钻井施工提供一定的借鉴。     

Study on Adsorption Behavior of Rare Earth Complexes on Nanometer-Size Titanium Dioxide with ICP-AES

Inrecentyears ,rareearthelements (REEs)havebeenwidelyusedinfunctionalmaterials ,cata lystsandotherproductsinindustry ,diagnosisreagentsofmagneticresonanceimaging (MRI)inmedicineandsomefertilizersinagricultureespeciallyinChina .However,asaresultoftheirusage ,moreandmoreREEsaregettingintotheenvironment,andalsointohumanbodyviafoodchain[1,2 ] .Itisnotclearwhetherrareearthelementsareessentialforman ,soitisveryurgenttostudythebiologicaleffectofrareearthelementsinhumanhealthandenvironment .Inthes…     

纳米技术在中药开发中的应用

本文综述了纳米科技与中药制剂相结合的发展，阐述了纳米中药的概念、特性，介绍了纳米中药的制备技术，另外探讨了收集纳米粒子的方法，最后，着重展望了纳米技术在中药制剂中广泛的应用前景。     

光学薄膜在光通信中的应用

主要介绍了光学薄膜在光通信的无源型器件中的原理及应用,并与光纤光栅和平面光波导型的无源器件作简单比较。     

纳米涂层的研究现状与展望

简述了纳米表面涂层制备工艺的研究现状，分析了气相沉积、热喷涂、电刷镀、化学镀和电沉积等不同工艺在制备纳米表面层中的应用情况。介绍了纳米涂层在超硬耐磨、耐腐蚀、耐高温热稳定性等方面研究的新进展，并对纳米涂层的应用范围和领域作了展望。     

化学镀SiCp／Ni－P复合镀层与基体结合强度及其影响因素

论述了ＳｉＣｐ／Ｎｉ－Ｐ复合镀层与钢基体的结合强度及其影响因素。复合镀层中离界面５μｍ厚度以内区域的组成及应力状态对镀层／基体的界面结合有决定性作用，在该区域以外ＳｉＣ粒径变化不影响镀层的结合强度。适当的热处理可提高界面结合力。     

Tetradecylthioacetic acid incorporated into very low density lipoprotein: changes in the fatty acid composition and reduced plasma lipids in cholesterol-fed hamsters

The mechanism behind the hypolipidemic effect of tetradecylthioacetic acid (CMTTD, a non-beta-oxidizable 3-thia fatty acid) was studied in hamsters fed a high cholesterol diet (2%), which resulted in hyperlipidemia. Treating hyperlipidemic hamsters with CMTTD resulted in a progressive hypocholesterolemic and hypotriacylglycerolemic effect. Decreased plasma cholesterol was followed by a 39% and 30% reduction in VLDL-cholesterol and LDL-cholesterol, respectively. In contrast, the HDL-cholesterol content was not affected, thus decreasing the VLDL-cholesterol/HDL-cholesterol and LDL-cholesterol/HDL-cholesterol ratios. 3-Hydroxy-3-methylglutaryl- (HMG) CoA reductase activity and its mRNA level were unchanged after CMTTD administration. Also, the LDL receptor and LDL receptor-related protein (LRP-4) mRNAs were unchanged. The decrease in plasma triacylglycerol was accompanied by a 45% and 56% reduction in VLDL-triacylglycerol and LDL-triacylglycerol, respectively. The hypolipidemic effect of CMTTD was followed by a 1.4-fold increase in mitochondrial fatty acid oxidation and a 2.3-fold increase in peroxisomal fatty acid oxidation. CMTTD treatment led to an accumulation of dihomo-gamma-linolenic acid (20:3n-6) in liver, plasma, very low density lipoprotein, and heart. Noteworthy, CMTTD accumulated more in the heart, plasma, and VLDL particles compared to the liver, and in the VLDL particle alpha-linolenic acid (18:3n-3) decreased whereas eicosatetraenoic acid (20:4n-3) increased. In addition, linoleic acid (18:2n-6) and the total amount of polyunsaturated fatty acids decreased, the latter mainly due to a decrease in n-6 fatty acids. The present data show that CMTTD was detected in plasma and incorporated into VLDL, liver, and heart. The relative incorporation (mol%) of CMTTD was heart > VLDL > liver. In conclusion, CMTTD causes both a hypocholesterolemic and hypotriacylglycerolemic effect in hyperlipidemic hamsters.     

Overexpression, purification, and characterization of SHPTP1, a Src homology 2-containing protein-tyrosine-phosphatase

A protein-tyrosine-phosphatase (PTPase; EC 3.1.3.48) containing two Src homology 2 (SH2) domains, SHPTP1, was previously identified in hematopoietic and epithelial cells. By placing the coding sequence of the PTPase behind a bacteriophage T7 promoter, we have overexpressed both the full-length enzyme and a truncated PTPase domain in Escherichia coli. In each case, the soluble enzyme was expressed at levels of 3-4% of total soluble E. coli protein. The recombinant proteins had molecular weights of 63,000 and 45,000 for the full-length protein and the truncated PTPase domain, respectively, as determined by SDS/PAGE. The recombinant enzymes dephosphorylated p-nitrophenyl phosphate, phosphotyrosine, and phosphotyrosyl peptides but not phosphoserine, phosphothreonine, or phosphoseryl peptides. The enzymes showed a strong dependence on pH and ionic strength for their activity, with pH optima of 5.5 and 6.3 for the full-length enzyme and the catalytic domain, respectively, and an optimal NaCl concentration of 250-300 mM. The recombinant PTPases had high Km values for p-nitrophenyl phosphate and exhibited non-Michaelis-Menten kinetics for phosphotyrosyl peptides.